CJ (001040) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
14 Jul, 2026Executive summary
Consolidated sales rose 8.0% year-over-year to 11,451.2bn KRW in Q1 2026, with operating profit at 460.7bn KRW and net income at 174.3bn KRW, driven by reduced interest expenses and improved FX gains.
Major business segments include Food & Food Service, Biotechnology, New Distribution (Logistics & Retail), and Entertainment & Media.
Olive Young and Logistics segments posted strong sales growth; ENM's Film & Drama sales improved.
Financial highlights
Revenue: 11,451.2bn KRW (+8.0% YoY); Operating Profit: 460.7bn KRW; Net Income: 174.3bn KRW (+31.4% YoY).
Gross margin decreased by 1.1 percentage points YoY to 27.8%.
SG&A expenses increased 7.6% YoY; operating margin fell to 4.0% from 5.0%.
EBITDA for Q1 2026 was 1,424.0bn KRW.
Basic EPS for Q1 2026 was 2,256 KRW.
Outlook and guidance
Olive Young to accelerate global expansion and domestic user acquisition in 2Q26, including US offline store launches and new loyalty program.
The group plans to accelerate global expansion in K-Food and logistics, invest in digital transformation, and strengthen its entertainment content pipeline.
Continued focus on cost control and portfolio optimization amid inflation and global economic uncertainty.
New dividend policy for 2026 to be disclosed later.
Latest events from CJ
- H1 2026 revenue up 5.8% YoY to KRW 22.98T; profit pressured by higher costs and divestitures.001040
Q2 2026 - Revenue up 1.6% YoY to ₩10.6T; logistics and food drive growth, profits pressured.001040
Q1 2025 - Revenue up 4.2% to ₩31.96T, operating profit up 30.9%, net profit down on higher taxes.001040
Q3 2024 - Sales and operating profit grew YoY, but net income turned negative on one-off impairment.001040
Q4 2024 - H1 2024 revenue up 5.2% YoY, operating profit up 50%, net profit up 33.6%.001040
Q2 2024 - Sales up 5.4% YoY to 11.4tn KRW; nine-month revenue ₩33.15tn; net income positive.001040
Q3 2025 - Sales and operating profit rose, but net loss widened due to asset impairments.001040
Q4 2025 - Sales up 4.1% YoY, H1 revenue ₩21.72T, net income rose, dividend policy reaffirmed.001040
Q2 2025